1-1 of 1
Authors: Hayley Wyper
Journal Article
P-596. Immunobridging Demonstrating Effectiveness of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Adults 18-59 Years of Age at High Risk of Severe RSV Disease in a Phase 3 Trial: The C3671023 MONeT Study Results
Open Forum Infectious Diseases, Volume 12, Issue Supplement_1, February 2025, ofae631.794, https://doi.org/10.1093/ofid/ofae631.794
Published: 29 January 2025
